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This paper introduces and discusses key issues in the economic evaluation of digital health 
interventions. The purpose is to stimulate debate so that existing economic techniques may be 
refined or new methods developed. The paper does not seek to provide definitive guidance on 
appropriate methods of economic analysis for digital health interventions. 
 
This paper describes existing guides and analytic frameworks that have been suggested for 
the economic evaluation of healthcare interventions. Using selected examples of digital 
health interventions, it assesses how well existing guides and frameworks align to digital 
health interventions. It shows that digital health interventions may be best characterized as 
complex interventions in complex systems. Key features of complexity relate to intervention 
complexity, outcome complexity, and causal pathway complexity, with much of this driven 
by iterative intervention development over time and uncertainty regarding likely reach of the 
interventions amongst the relevant population. These characteristics imply that more-complex 
methods of economic evaluation are likely to be better able to capture fully the impact of the 
intervention on costs and benefits over the appropriate time horizon. This complexity 
includes wider measurement of costs and benefits, and a modeling framework that is able to 
capture dynamic interactions among the intervention, the population of interest, and the 
environment. The authors recommend that future research should develop and apply more-
flexible modeling techniques to allow better prediction of the interdependency between 
interventions and important environmental influences. 
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Introduction 
The purpose of economic evaluations of digital health interventions (DHIs) is to inform 
decision makers about the relative value for money of those interventions against specified 
alternatives. With resource scarcity, it is argued that use of resources will be more efficient if 
they are allocated to interventions where the magnitude of additional benefits relative to the 
magnitude of additional costs is greatest, subject to an identified budget constraint. 
 
There are several ways to conduct an economic evaluation of health interventions. One of the 
most common is cost-utility analysis. This measures benefits in terms of quality-adjusted life 
years, which is a measure of length of life weighted by quality of life to reflect desirability of 
that life (scaled from 0 to 1, where 0=dead and 1=perfect health). Other analyses include 
cost-effectiveness analysis, which measures benefits in terms of clinical units, such as 
whether an individual is free of symptoms, and cost-consequences analysis, an extended form 
of cost-effectiveness analysis, where multiple benefits are measured and reported separately. 
Within other public policy fields, such as environment and transport appraisal, the technique 
of cost-benefit analysis is the most common type of evaluation, with the benefits of programs 
being measured in monetary terms. 
 
Several sets of guidelines for the design and conduct of economic evaluation exist for 
healthcare studies,1 but the extent to which these are relevant to DHIs has received little 
attention. The term ³'+,V´ in this paper refers to interventions that employ digital 
technology to promote and maintain health, through supporting behavior change or decision 
making of the general public, patients, or healthcare practitioners. Interventions are typically 
automated, interactive, and personalized, employing user input or sensor data to tailor 
feedback or treatment pathways (e.g., a smartphone app to promote greater levels of physical 
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activity would be one example). In telemedicine and telecare, which may be components of 
some DHIs, systematic reviews suggest there is a lack of good evidence regarding costs and 
therefore cost effectiveness,2,3 and this partly arises through lack of methodologic rigor 
within the original published studies.4 
 
This paper does not seek to provide definitive guidance on appropriate methods of economic 
analysis for DHIs, but instead aims to highlight key issues in the economic evaluation of 
DHIs, to stimulate debate so that refined economic tools and methods may be developed. The 
paper is organized as follows. First, it describes existing guides and analytic frameworks 
suggested for the economic evaluation of interventions applied to complex interventions. 
Second, using selected examples of DHIs, it assesses how well existing guides and 
frameworks map to DHIs. Third, it proposes key decision points in the design and conduct of 
economic evaluations. 
 
Existing Analytic Frameworks 
International Society for Pharmacoeconomics and Outcomes Research Good Research Practice 
Guide 
To enhance the conduct and reporting of trial-based economic evaluation studies applied to 
new medicines, medical devices, and procedures, the International Society for 
Pharmacoeconomics and Outcomes Research has published an updated good research 
practice guide.1 This re-emphasizes the need to base economic evidence on effectiveness 
rather than efficacy, the benefits from direct data collection on resource use and health states 
(or other measures of effectiveness) from study participants rather than indirectly (such as 
mapping), and recognizing that study designs such as RCTs are complementary to model-
based evaluations. These recommendations appear salient for evaluation of DHIs. For 
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example, there is already recognition that RCTs are not always appropriate as a means to 
establish effectiveness,5 and a similar argument holds for evaluation of cost effectiveness. 
 
In some specific areas, however, the recommendations may be less appropriate for DHIs. For 
example, where interventions are designed to bring about health behavior change, it can be 
argued that they differ from medicines, devices, and procedures in terms of intended 
mechanisms of action. Here, notions of mechanism of action confined to biological 
interactions within single individuals have been significantly developed and refined,6±9 to 
accommodate importance of interaction with the health and social care system, or the wider 
social environment. 
 
One area in particular where there may be a need for a different approach relates to the use of 
intermediate (surrogate) measures of benefit. The International Society for 
Pharmacoeconomics and Outcomes Research guide recommends that the XVHRI³LQWHUPHGLDWH
RUVXUURJDWH´PHDVXUHVVKRXOGEHDYRLGHGLQWKHPHDVXUHPHQWRIEHQHILWZKHUHYHUSRVVLEOH
However, when the expected effects of an intervention are only likely to be observed in the 
long term, the guide suggests that surrogate measures are appropriate, as long as the 
rHODWLRQVKLSWR³ILQDO´PHDVXUHV (e.g., mortality, health-related quality of life, or well-being) 
is firmly established. A focus on surrogate measures may not be sufficient in circumstances 
where intervention adapt and change over time, where the mechanisms of action are unclear, 
and where effectiveness and cost effectiveness are theorized to relate closely to the system or 
environment in which they are placed. In short, existing guidelines such as the International 
Society for Pharmacoeconomics and Outcomes Research guide, which are available for 
medicines, devices, and procedures, may require amendment for many DHIs. 
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Medical Research Council Framework for Complex Interventions 
A DHI can be characterized as D³complex intervention´ in a complex system.10±12 Within the 
Medical Research Council Framework for the Evaluation of Complex Interventions,13 a 
complex intervention is one that ³contains several interacting components, and other 
characteristics, such as the number and difficulty of behaviors required by those delivering or 
receiving the intervention.´Complexity may also refer to features of the system in which an 
intervention is implemented, as well as the intervention itself. Shiell et al.12 QRWHWKDW³D
complex system is one that is adaptive to changes in its local environment, is composed of 
other complex systems, and behaves in a non-linear fashion (i.e., change in outcome is not 
proportional to change in input).´Petticrew and colleagues14 outline this further by drawing 
distinctions among intervention complexity, outcome complexity, and causal pathway 
complexity: 
x intervention complexity: 
o multiple, interacting components 
o likely to be tailored, adapt, or change over time 
x outcome complexity: 
o spillovers and externalities (i.e., outcomes go beyond the immediate recipient 
of the intervention, such as influencing the behavior or health of other family 
members) 
o feedback loops (i.e., the uptake of the intervention may be affected by uptake 
E\RWKHUV³VRFLDOFRQWDJLRQ´HIIHFW) 
x causal pathway complexity: 
o multiple moderators and mediators of the relationship between intervention 
and outcomes, particularly strong influence of system characteristics (i.e., the 
setting/context of the intervention is important and likely to generate 
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heterogeneity in costs and benefits, through differences in resource 
availability, culture, beliefs, attitudes, interpersonal relationships) 
o non-linear relationships between intervention resource inputs and multiple 
RXWSXWV³SKDVH´FKDQJHV(i.e., sudden, unpredictable tipping points) 
 
A key question is the extent to which DHIs map to the above types of complexity. Clearly 
some may align with the above classification more than others. For example, consider a 
health app for the management of Type 2 diabetes²if additional input from healthcare staff 
is required according to individual patient goals or preferences, or if the intervention partly 
comprises an element of feedback from healthcare staff, then this gives rise to intervention 
complexity²the intervention is highly individualized and heterogeneous. There may also be 
outcome complexity; for example, if the individual needs to change food and alcohol intake, 
then other household members may also have to change, but may be resistant to this. Further, 
if the app includes the option of information exchange with other users, such as electronic 
posting of achieved goals, this could affect behavior in a positive or negative way. Finally, 
there may need to be a set of necessary conditions in place for the intervention to be effective, 
especially in the longer term; these could relate to a set of motivational factors, such as prior 
diabetes history, other patient characteristics (education, income, and time preference in 
terms of willingness to invest time and effort today to achieve additional benefits later), and 
wider contextual factors, such as an individual being within a social network where members 
already XQGHUWDNH³KHDOWK\EHKDYLRUV.´7KHVHFRQGLWLRQVJLYHULVHWRFDXVDOSDWKZD\
complexity. Taken together, it could be argued that the health app intervention is a complex 
intervention in a complex system. Conversely, other DHIs for the same condition may exhibit 
less complexity; for example, if there is little or no interaction with healthcare professionals 
or other recipients, then causal pathway complexity is likely to be smaller. 
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Taking forward these notions, Shiell et al.12 draw out some lessons for economic evaluation; 
it is argued that, where a complex intervention lacks significant interaction with the setting 
(i.e., where the casual pathway is relatively simple), current methods of economic evaluation 
might be sufficient (i.e., identifying, measuring, and valuing resource use and weighing that 
against the value of health or other outcomes that are produced). However, where there is 
significant interaction with setting, there are potentially additional challenges for economic 
evaluation. These include more difficult choices regarding what measures of effectiveness 
should be included, how consequences should be valued, and how evaluation should be 
conducted. More fundamentally, there may be significant challenges associated with 
historicity or path dependence. For instance, the past 20 years have seen a marked change in 
public acceptability of smoking and use of mobile devices, so it may be hypothesized that a 
DHI intervention to encourage smoking cessation may have achieved very different effects at 
any point during that period. These challenges may lead therefore to a need to conduct a 
³complex economic evaluation´ (e.g., attempting to estimate cost effectiveness for subgroups 
according to the extent of interaction with the system or with each other. Note, however, that 
LWLVVWLOOOHJLWLPDWHWRFRQGXFW³VLPSOH´ evaluations of complex interventions, by addressing 
³VLPSOH´TXHVWLRQV14 such as what the average change in health and costs is after intervention 
receipt, relative to usual care). Ultimately, the type of conducted evaluation will depend on 
the research question, as well as extent of interaction, between intervention and 
system/setting, or between individuals, and the importance this has for generating 
heterogeneity in costs and benefits. 
 
To illustrate what a complex economic evaluation might look like, consider Zhang and 
colleagues,15 who used an agent-based model of social network interactions to examine the 
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effect of different policy instruments in changing dietary behaviors (Figure 1). Based on a 
multilevel theory of population health that encompasses habitual behaviors,16 behaviors are 
influenced by standard economic incentives, such as price, but also affected by cognitive 
habits that are subject to social norms. The model simulated potential policy impacts (e.g., 
taxation), and could be extended by incorporating data from natural experiments and health 
administrative records, to examine influences on health, well-being, and costs to the 
healthcare system. 
 
Whether simple or complex, a key factor in economic evaluation relates to judgement 
regarding the time frame for the expected effects to occur. This creates a challenge for DHIs 
as the content of many interventions evolves over time, and there may be a protracted period 
before benefits are observed. Conventional approaches have usually been built on the RCT. 
The RCT is designed to determine whether the relationship between a constant (the 
independent variable) and the outcome of the interaction it has with the environment into 
which it is applied is free from bias. So long as the intervention is constant, then this is 
appropriate. But some DHIs are not constant, with many evolving as they are implemented. 
As a result, the artificial nature of RCTs may mean that they are not good vehicles to indicate 
the potential impact of DHIs. 
 
If trials with randomization at the individual level are potentially problematic, what are the 
alternative options? Aside from cluster randomization, other study designs such as natural 
experiments are possible.17 For example, the five test bed sites within the National Health 
Service (NHS) England provide a vehicle to examine effectiveness and cost effectiveness on 
a large scale.18 However, use of quasi-experimental or observational study designs to 
demonstrate effectiveness also carries limitations, such as inability to control for unobserved 
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variables.17 More fundamentally, in many cases, an evaluation will be needed by decision 
makers before the DHI has been trialed, and in cases where a trial does proceed, by the time it 
is nearing completion, both its effectiveness and cost effectiveness will already be ³known´ 
with sufficient accuracy before real-world data are available. This may then provide 
disincentives for the future use of real-world data to examine effectiveness and cost 
effectiveness. This suggests that a decision-theoretic approach will be required (and may be 
sufficient by itself) in some circumstances, such as where the intervention could not 
conceivably cause harm, and where the likely effect size would produce an estimate of cost 
effectiveness that is well below currently acceptable thresholds.19,20 For example, in a hand 
washing intervention designed for use in an influenza pandemic,21 international dissemination 
of a fully automated digital intervention to reduce spread of respiratory infection would likely 
result in healthcare savings and wider health and socioeconomic benefits so great that the cost 
of the intervention becomes negligible. 
 
Within the framework of complex interventions in complex systems, a critical factor driving 
effectiveness may be the extent of uptake by a social network or other relevant population. 
The argument here is that changes in health behavior can be spread or transmitted from one 
individual to another within a social network; the parallel is earlier work on obesity and the 
idea that this is partly a social disease, through a clustering effect.22 In similar fashion, the 
effectiveness and cost effectiveness of DHIs may depend on diffusion through social 
networks for uptake and effect. For example, an Internet-delivered hand washing intervention 
resulted in reductions in respiratory infection in the user and also in family members who had 
not engaged with the intervention directly,21 and smaller effects could spread more widely. In 
addition, there may be feedback loops and potentially non-linear relationships, such as 
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effectiveness at the individual level being partly dependent on nature of uptake at the group 
level (e.g.www.gettheworldmoving.com).23 
 
Since Christakis and Fowler,22,24,25 there has been an explosion of epidemiologic studies 
using social network analytic methods for describing and understanding network effects.26 
However, there have been far fewer published attempts to use such methods as the basis for 
the design and evaluation of DHIs.27,28 This may be because development of experimental 
methods in social networks analysis is still at a relatively early stage,29,30 and there is need to 
develop the wider use of modeling techniques for predicting social network effects.31 
 
Implications of Applying the Complexity Framework for Economic 
Evaluation of Digital Health Interventions 
In situations where it is judged that applying standard methods of economic evaluation may 
not be optimal, there are implications for costs as well as for benefits, and also major 
challenges for selection of the appropriate modeling framework. These issues are examined 
below, by discussing implications in three areas: inclusion of development costs, 
measurement of benefits and resource use impacts, and the appropriate modeling framework. 
 
Inclusion of Development Costs Plus Maintenance and Running Costs, or Only the Latter? 
The vast majority of costs are incurred during development. Development costs may include: 
x literature reviews, summarizing available evidence on:  
o the condition addressed by the DHI (causes, treatments); 
o interventions likely to be effective if delivered digitally (e.g., tailored 
content, behavior change techniques, emotional support); 
x De novo UHVHDUFKLGHQWLI\LQJXVHU³ZDQWVDQGQHHGV´ 
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x costs of content development (this will vary with the intended goal of the DHI, 
but may include information provision, behavior change interventions, 
decision support, emotional or psychological interventions, opportunities to 
interact online with peers or healthcare professionals) 
x costs of design features (navigation, images, videos, graphics) 
x costs of software features (interactivity, algorithms, tailoring) 
x costs of user experience testing 
These costs can be substantial, ranging from £20,000 (for a simple one-session intervention)32 
to £500,000 (or more) for a longitudinal, highly interactive intervention with extensive 
content, tailored to many different variables.33 Many of these costs relate to iterative 
development and evaluation of the intervention to maximize acceptability and feasibility.34,35 
By contrast, maintenance costs can be very low. The minimum maintenance cost is hosting. 
Costs of hosting vary according to DHI complexity and required levels of security and 
response times. 
 
Although the issue of whether to include development costs and other costs such as training 
costs and future costs of related diseases and treatments is not specific to DHIs, there are 
three additional considerations that may be peculiar to DHIs: 
x Most DHIs UHTXLUHUHJXODUXSGDWLQJWRUHPDLQ³WKHVDPH´(e.g., where the DHI 
promises to deliver up-to-date information). Updating is required for content, 
navigation and visuals, and software. As mainstream software manufacturers update 
their products, DHIs that are not updated will cease to function. 
x As outlined in Yardley et al.,36 there is good evidence that DHIs alone are often not as 
effective as DHI plus human support or facilitation, where the human input focuses on 
getting the patient (user) to use the DHI as intended.37,38 Unlike all other costs 
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associated with DHIs, which are fixed, these facilitation costs are variable as they 
increase with each additional user. 
x Many interventions are likely to evolve unpredictably over time. Such change makes 
reproducibility more challenging, and data collection difficult if the change was quick 
and no measurement of resource use was planned. Where change is planned as part of 
the intervention, this knowledge should be built into the cost estimates, otherwise 
there is a danger that the costs incurred in a research study may not be fully reflective 
of resource use outside of that setting.35 
 
The issue of perspective (i.e., whether the evaluation is conducted from a payer perspective, 
societal perspective, or some other perspective) is also important in judging the importance of 
inclusion of development costs. From the perspective of a national health regulator such as 
the National Institute of Health and Clinical Excellence, the decision may be whether to 
develop a DHI de novo and make it available as a public good (i.e., once it is provided to at 
least one individual, it can be provided to an unlimited number of other people at no further 
cost). Here, good estimates of fixed costs of development are important, alongside knowledge 
regarding resources required for storage, data retrieval, and encryption. The payer (the NHS) 
would then agree a price with the manufacturer to cover these costs, together with a potential 
markup to protect intellectual property. However, other perspectives than those of a national 
regulator can be adopted, and other factors, such as whether the DHI is a modification of an 
existing product, will have implications for the inclusion or exclusion development costs 
within the evaluation. For example, for evaluation of existing products, prior development 
costs would usually be excludHGDVWKHVHDUH³VXQNFRVWV´ because there is no further 
resource impact for decision makers going forward, but resources required for modification 
would be included. Further, likely product reach and future costs of updating as technology 
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changes are both highly unpredictable, and may be further affected by regulatory changes. 
Information on reach is important in estimation of cost effectiveness as the marginal costs per 
additional user will tend to zero as the population size. This is not a trivial task, requiring 
additional effort and data analysis.39 
 
Measurement of Benefits and Resource Use Impacts 
The measurement of benefit should relate to the purpose of the individual technology²what 
is it trying to achieve over a particular time frame? This is important because it acts as the 
key guide to how benefits are measured. The main categories of benefit include the 
following: 
x health effects in their natural units (e.g., number of avoided cancer cases) 
x generic measures of healthy time or other outcomes (e.g., quality-adjusted life years 
x monetary valuation of healthy time or other outcomes (e.g., willingness to pay to gain 
percentage increase in healthy life years) 
Less common approaches include measurement of changes in well-being (e.g., capability), 
the extent to which an individual feels it is possible for them to live a meaningful life,40 or 
measures of life satisfaction. 
 
It is clear that different interventions are designed to achieve different objectives, some of 
which may relate to reductions in service use. For example, DHIs for diabetes and for 
patients receiving warfarin41 are intended to reduce the need for monitoring visits with NHS 
staff. Outcomes have been measured as change in utilization of healthcare resources, patient 
satisfaction, and maintained control of symptoms. For such DHIs, it seems plausible to 
maintain an NHS perspective for costs and outcomes (i.e., only health effects), and health and 
social care costs may be deemed relevant for evaluation. However, even here, it could be 
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argued that a wider perspective is warranted, as patient monitoring of symptoms may increase 
reassurance and empowerment, but may also lead to adverse effects, such as anxiety and 
intrusiveness. For other DHIs however, the range of benefits may be much wider and 
individual health effects may take longer to occur. These include Internet-based programs 
and apps to encourage a lifestyle change, such as weight loss, exercise, or sleep behavior, 
which may result in health changes as well as other effects, such as greater social inclusion 
and productivity changes. 
 
Finally, an important issue relates to safety. There may be unintentional and intentional 
harms. For example, a weight loss mobile app shared among teenage girls may lead to 
unintended consequences such as an increase in smoking. Digital apps also exist to help 
individuals to commit suicide. Some provide advice that is opposite to existing guidelines. 
National regulation is therefore important. Equally, regulation is appropriate to protect 
consumers from fraudulent apps, such as those purporting to measure blood alcohol 
concentration, but with no capacity to do so.42 Further, harm may occur if information or 
advice in a DHI is inaccurate or out of date, or through misinterpretation by the user. DHIs 
may also cause anxiety or feelings of inadequacy if users feel burdened by them.43 
 
Appropriate Modeling Framework 
Finally, there is the challenge of bringing costs and benefits together in the appropriate 
modeling framework. To conduct evaluations that account for the degree of complexity that 
is relevant to the intervention and setting, it is vital that economic modelers develop or apply 
better tools to encapsulate individual- and population-level interactions, rather than impose 
highly simplified assumptions or heuristics about the nature of human behavior.44 These 
models and the techniques to develop them should be more widely embraced in economic 
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analysis of DHIs.45 As highlighted earlier,15,16 there appears a role for agent-based 
modeling.46,47 Within this approach, individuals make decisions autonomously, as well as 
interacting with others DQGZLWKWKHLUHQYLURQPHQWXVLQJLQGLYLGXDOO\WDLORUHG³EHKDYLRUDO
rules.´These rules can be non-linear (e.g., discontinuous) and time-dependent (e.g., agents 
adapt and learn from previous experience). 
 
There is ample scope for methodologic development in economic modeling in this field. A 
possible starting point may be a critical review of existing interventions and development of 
novel case studies. For example, an ongoing European Union collaboration is examining 
aspects of complexity relevant to complex interventions in complex settings.48 Many of these 
aspects are potentially relevant when considering DHIs, including the impact of multiple 
interacting agencies involved in the intervention and the wider system; problems with 
defining the intervention owing to characteristics like flexibility, tailoring, self-organization, 
adaptivity, and evolution over time; and issues of historicity or path dependence, whereby the 
evolution of the system through series of irreversible and unpredictable events means that 
generalizability and repeatability of an intervention is problematic. 
 
Concluding Comments³Key Decision Points in the Design and Conduct of 
Economic Evaluations for Digital Health Interventions 
There is considerable scope for variation in how a particular DHI is delivered to a potential 
user, and the way in which that user then interacts with that intervention and the wider 
environment. Moreover, feedback mechanisms may be critical to the success of that 
intervention, such that the wider environment has a strong effect on how a recipient uses a 
particular intervention. In short, many DHIs may be best characterized as complex 
interventions within a complex system, and within the class of complex interventions, they 
17 
may hold special characteristics that require key questions to be addressed when planning the 
design of an economic evaluation, as outlined in Table 1. 
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List of Figures 
 
Figure 1. Model of unhealthy dietary behaviors. Reproduced from Zhang et al. (2014). 
 
Notes: The aim of the model is to compute probabilities of healthy and unhealthy food 
FRQVXPSWLRQIURPWKHHVWLPDWHGUHJUHVVLRQFRHIILFLHQWVĮ	ȕ7KHDJHQW-based model 
comprises 2 agents: individuals and food outlets. Individuals make dietary choices, and food 
outlets adapt to those choices. 
 
Individuals are assigned demographic characteristics (age, gender, educational attainment) to 
match the demographic profile of the local area. Individuals are assigned a home location and 
a set of friends, both constant throughout the modelling period. 
 
Food outlets were categorized as selling fresh fruit and vegetables (FV), or fast food (FF). 
Individuals chose to consume FV or FF each period on the basis of taste preferences, health 
beliefs, a food-price index, price sensitivity, food accessibility, and demographic factors (age, 
gender, and education). The weight assigned to each factor is based on data derived from an 
attitudinal and behavioral survey, supplemented by other empirical studies. Taste preferences 
and health beliefs are updated in each period according to prior habits, social network 
influences, and food marketing strategies. 
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Table 1. Key Guidance Points and Priority Topics for Future Research 
Guidance points based on existing research 
x Assess whether an intervention is complex, e.g., does it involve adaptive intervention 
components or interaction with other people? Is the causal pathway from intervention 
to outcomes complex? i.e., are there multiple mediators or moderators of outcomes? 
x Consider whether a complex economic evaluation is appropriate. (e.g., can the 
UHVHDUFKTXHVWLRQEHDGGUHVVHGXVLQJ³VWDQGDUG´PHWKRGVRIHFRQRPLFHYDOXDWLRQ
which do not require modelling of patient-system-network relationships to generate 
robust cost and benefit estimates?) 
x For a given study perspective, identify the relevant and important costs that should be 
included in an economic evaluation. (e.g., should all the resources used in the 
development of the DHI be included? Alternatively, is it acceptable to focus solely on 
measurement of the health care resources and any other resources required in future 
maintenance and support of DHIs?) 
x For a given study perspective, identify the relevant and important benefits that should 
be included in an economic evaluation. (e.g., benefits are likely to be multi-faceted 
and potentially span beyond health, creating a challenge for measurement, e.g., does 
engagement with DHIs facilitate future employment prospects for some individuals? 
Are there other spin-offs? Are there negative effects? What effect does the DHI have 
on the wider environment, and what effect does the environment have on the DHI?) 
Priority topics for future research 
x Critical review of existing economic evaluations of digital health interventions, with 
particular focus on comparative studies that have undertaken different modelling 
approaches 
x Validation of agent-based models that capture dynamic interactions between the 
intervention, the population of interest and environment 
x Further interrogation of existing datasets to permit better estimates of reach and 
uptake of new digital health interventions 
x Exploration of how best to incorporate economic factors into intervention design and 
re-design 
DHI, Digital Health Intervention 
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